Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EraMune 02: Intensification + Vaccination for HIV Eradication
NCT00976404Phase 2Completed
- Start
- Nov 2009
- Primary completion
- Jul 2013
- Modality
- Prophylactic Vaccines, Viral Vectors, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of EP-1090, HIV rAd5 vaccine in human immunodeficiency virus infection (HIV). Started Nov 2009; status: completed.
02
Drugs
EP-1090HIV rAd5 vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00976404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976404.